NRX Pharmaceuticals's total assets for Q2 2026 were $34.16M, an increase of 186.99% from the previous quarter. DE:B1Q total liabilities were $34.33M for the fiscal quarter, a 33.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.